News
LMS Capital joins LPEQ
LMS Capital Plc has joined the LPEQ group of European listed private equity companies.
Centocor acquires RespiVert from Advent
Advent Venture Partners and other investors have sold their stakes in drug discovery company RespiVert.
Diet Chef receives £3m from Piper Private Equity
Diet Chef, the UK-based diet meals delivery company, has received £3m from Piper Private Equity to expand its operations.
Investinor et al. invest $4.2m in ExproSoft AS
Norwegian private equity funds Investinor and Viking Venture have acquired a 42.3% share of ExproSoft AS.
PAI Partners looking to sell Kwik-Fit
PAI is believed to have put Kwik-Fit's car-repair operation up for auction, looking for £250m. It's insurance branch already on the market.
Catapult invests £1.1m in Biofortuna
Catapult Venture has invested £1.1m into a molecular diagnostics company Biofortuna Ltd.
AGF Private Equity becomes IDInvest Partners
IDI Group has finalised the buyout of French private equity firm AGF from Allianz.
Finance Wales backs AssayMetrics
Finance Wales has led an early-stage investment in UK biotechnology company AssayMetrics. No financial details have been disclosed.
Darwin buys Plum Baby
Darwin Private Equity has acquired UK food producer, Plum Baby, for £10m.
AAC Capital buys UK pharma company for £100m
Martindale Pharmaceuticals, the UK based methadone maker, has been bought by AAC Capital Partners for £100m.
Linklaters promotes Paul Lignieres to managing partner
Linklaters has appointed Paul Lignieres as managing partner of its Paris office.
Javier Echarri confirms EVCA departure
After 10 years as secretary general for the European Private Equity & Venture Capital Association, Javier Echarri is set to pass the torch by the end of the year.
NewVoiceMedia gets £4m boost from Eden Ventures and Notion Capital
Eden Ventures and Notion Capital have provided £4m in expansion capital to UK technology vendor, NewVoiceMedia.
NorthStar leads £1.6m investment in Reinnervate
NorthStar Equity Investors has led a £1.6m funding round for start-up biotechnology company, Reinnervate.
Energy Ventures et al. invest £3.15m in Stingray Geophysical
Oil equipment and services company Stingray Geophysical has secured a £3.15m investment from its existing shareholders Energy Ventures, Cody Gates Ventures, Chevron Technology Ventures and Statoil Ventures. Management also took part in the transaction.
TVM Capital restructures; hires Schuler
TVM Capital has reorganised its life science investment practice. In the future, the firm will operate two dedicated teams with differentiated investment concepts to invest in pharmaceutical, biopharmaceutical, medical technologies (medtech) and healthcare...
Perfectis sells Louisiane to Finadorm
Perfectis Private Equity has sold its controlling stake in mobile home manufacturer Louisiane to the Finadorm Group for an undisclosed sum.
NGN Capital leads €33m series-D round for NOXXON Pharma AG
NGN Capital has led a €33m series-D round in NOXXON Pharma. NGN is a new investor and was joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow...
Future Capital hires Alan Cross
Future Capital Partners has hired Alan Cross as business development manager, to focus on the marketing of its recently launched investment initiative, Future Fuels.
Epi-V hires Dominic McCann as oil and gas advisor
Epi-V has bolstered its oil and gas deal-making team with the appointment of Dominic McCann as an independent technology advisor.
AGF injects €12m in online poker company
AGF Private Equity has invested €12m in online-gaming company Winamax Holdings.
NorthStar leads £1.6m round in Reinnervate
NorthStar Equity Investors has led an investment round of over £1.6m in biotech start-up Reinnervate Limited.
Ventech invests €10m in Funxional Therapeutics
French private equity firm Ventech entered the series-B financing round as a new investor, alongside existing backers Index Ventures and Novo A/S.
KBC drops talks on sale of private equity unit
Belgium-based KBC has dropped negotiations with AXA Private Equity and Sofina on the sale of its private equity business, according to reports.